TWM
GILD icon

TRB Wealth Management’s Gilead Sciences GILD Stock Holding History

TRB Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$574K Buy
4,540
+75
+2% +$9.88K 0.08% 131
2026
Q1 		$622K Buy
+4,465
New +$625K 0.09% 124

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TRB Wealth Management's GILD Position: Q2 2026 in Review

TRB Wealth Management increased its Gilead Sciences (GILD) stake by 1.7% in Q2 2026, buying an estimated $9.88K and bringing the position to 4,540 shares worth $574K. The position accounts for 0.08% of the portfolio, ranked #131.

TRB Wealth Management first reported a position in GILD in Q1 2026 and has held it in 2 quarters since. The position peaked at $622K in Q1 2026. 2,260 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • TRB Wealth Management held 4,540 shares of Gilead Sciences worth $574K as of Q2 2026.
  • TRB Wealth Management bought 75 Gilead Sciences shares in Q2 2026, an estimated $9.88K.
  • Gilead Sciences made up 0.08% of TRB Wealth Management's portfolio in Q2 2026, its #131 holding.
  • TRB Wealth Management first reported a position in Gilead Sciences in Q1 2026 and has held it in 2 quarters since.
  • TRB Wealth Management's Gilead Sciences position peaked at $622K in Q1 2026.
  • 2,260 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on TRB Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.